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Abstract
Objectives: To study the clinical characteristics and laboratory profile of systemic lupus erythematosus (SLE) in children in a tertiary 
care center. Methods: Children presenting to our tertiary care center with suspected SLE, fulfilling at least 4 out of 11 American College 
of Rheumatology (ACR) criteria for the diagnosis of SLE were reviewed retrospectively. The study period was from June 2012 to May 
2015. The clinical presentation and laboratory parameters were analyzed. Results: A total of 14 patients fulfilled the ACR criteria; there 
were 12 girls and 2 boys with a sex ratio of 1:6 favoring girls. The mean age on presentation was 9.8 years with a range of 3-15 years. 
At presentation, 70% of the children had features not suggestive of SLE. The most common symptom was fever seen in 100% of the 
patients, followed by hematological abnormalities in 78%, and renal involvement in 57% patients. Arthritis, skin lesions, and pulmonary 
involvement were seen in 42% of the patients. The gastrointestinal presentation was seen in 21% of the patients. Conclusion: SLE has a 
varied clinical presentation depending on the predominant organ involved. A high index of suspicion is required for the early diagnosis 
of SLE in children.
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Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown etiology. The pathogenesis is complex with immunological, genetic, hormonal, and 
environmental factors contributing to it. It is characterized by 
damage to various cells through pathogenic autoantibodies 
and immune complexes. It has diverse clinical features with 
remissions and relapses affecting the diagnosis and treatment 
strategies [1]. In the past, it was suggested that SLE is a rare 
disease in children. This was largely because of mild and 
early cases were being missed until end organ damage made 
the diagnosis evident. The clinical characteristics appear to 
be similar to adults but, lymphadenopathy and early renal 
and nervous system involvement are common in childhood 
SLE [1,2]. Furthermore, children tend to have more severe and 
more aggressive disease compared to adults [2,3].
SLE can also present with some unusual presentations 
initially which will make the clinical diagnosis difficult unless 
the clinician has a high index of suspicion [4-7]. There are 
reports of geographical variations in the clinical presentation 
of childhood SLE in different areas in India itself [2]. As there 
is a paucity of data in the childhood SLE, the present study 
was undertaken to evaluate the profile of pediatric patients 
presenting to our tertiary care hospital with SLE.
METHODS
This retrospective study was conducted in a tertiary care teaching 
hospital from June 2012 to May 2015. After obtaining clearance 
from the College Ethical Committee, retrospective review 
of medical records of patients admitted with SLE was done. 
Children with multisystemic involvement with the atypical 
course and high erythrocyte sedimentation rate (ESR) prompted 
for evaluation and diagnosis for SLE. Children found to have 
antinuclear antibodies (ANA) positivity and fulfilling at least 
4 out of 11 American College of Rheumatology (ACR) criteria 
for the classification of SLE (Table 1) at the time of presentation 
or subsequently were included in the study [8]. Children with 
clinically suspected SLE but not fulfilling ACR criteria were 
excluded from the study. Their age, sex, demography, clinical 
and laboratory parameters including complete blood counts, 
platelet count, ESR, peripheral smears, urine routine, urinary 
protein excretion, renal functions, and ANA profile were entered 
in a predesigned format. The data collected were analyzed using 
SPSS software version 20.
RESULTS
Total 14 patients fulfilled the ACR criteria during the study 
period; out of which, 12 were girls and 2 were boys with a sex 
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ratio of 1:6 favoring girls. The mean age on presentation was 
9.8 years with a range of 3-15 years.
Clinical features of the study population are presented 
in Table 2. The initial presentation varied from pyrexia of 
unknown origin (PUO), anemia, pneumonia, and seizure 
disorder. Non-specific constitutional symptoms were the 
most common presenting feature and fever was present in all 
14 (100%) of the patients. Lupus nephritis was seen in 8 (57%) 
cases on the renal biopsy. Renal involvement was seen in 
8 (57%) of patients in the form of asymptomatic proteinuria, 
nephrotic syndrome, and nephritis, one patient had presented 
with acute renal failure (Fig. 1).
Musculoskeletal symptoms varying from 6 to 12 weeks of 
duration were seen in 6 (42%) of the cases, they included on 
and off arthralgias and myalgias in 4 cases, and 2 cases had 
presented with frank arthritis. Serositis was seen in 7 (50%) 
cases. 6 (42%) cases had pulmonary involvement including two 
cases of pleural effusion with lupus pneumonia and 4 (28%) 
cases of pulmonary hemorrhage with pulmonary hemosiderosis. 
Neuropsychiatric features including seizure disorder and 
chronic headache were seen in 5 (35%) cases. Skin lesions 
were seen in 6 (42%), and oral ulcers, cardiac involvement, and 
lymphadenopathy were seen in 4 (28%) patients (Figs. 2-5).
Table 1: Revised ACR classification criteria for SLE [8]
Item Definition
Malar rash Fixed erythema, flat or raised, over the malar eminences, sparing nasolabial folds
Discoid rash Erythematous, raised patches with adherent keratotic scaling and follicular plugging; 
atrophic scarring may occur in older lesions
Photosensitivity Skin rash as a result of unusual reaction to sunlight by history or on physical exam
Oral ulcers Oral or nasopharyngeal ulceration, usually painless, observed by physician
Non-erosive arthritis Involving two or more peripheral joints, characterized by tenderness, swelling, or effusion
Pleuritis/pericarditis a.  Pleuritis - convincing h/o pleuritic pain or rub or pleural effusion on physical 
examination OR
b. Pericarditis - documented by ECG, rub or e/o effusion
Renal disorder a. Persistent proteinuria >0.5 g/day or >+++, OR
b. Cellular casts - May be red cell, Hb, granular, tubular or mixed
Neurological disorder a.  Seizures - in the absence of offending drugs, or known metabolic derangement, 
e.g., uremia, ketoacidosis or electrolyte imbalance, OR
b.  Psychosis - in the absence of offending drugs, or known metabolic derangement, 
e.g., uremia, ketoacidosis or electrolyte imbalance
Hematological disorder a. Hemolytic anemia with reticulocytosis, OR
b. Leukopenia <4000/cumm on two or more occasions, OR
c. Lymphocytopenia <1500 on two or more occasions, OR
d. Thrombocytopenia <100,000/cu mm in the absence of offending drugs.
Immunological a. Anti-DNA: Antibody to native DNA in abnormal titer, OR disorder
b. Anti-Sm: Presence of antibody to Sm nuclear antigen, OR
c.  Positive finding of aPL antibodies based on: (1) ↑ Serum level of IgG or IgM aCL or 
(2) a positive test result for lupus anticoagulant, using a standard method, or (3) a 
false-positive test for syphilis for at least 6 months and confirmed by TPI or FTA-abs test 
Positive ANA An abnormal titer of ANA by immune-fluorescence or an equivalent assay at any point in 
time in the absence of drug
FTA: Fluorescent treponemal antibody, ACR: American College of Rheumatology, SLE: Systemic lupus erythematosus, 
aCL: Anticardiolipin, IgM: Immunoglobulin-M, ANA: Antinuclear antibodies, FTA-abs: Fluorescent treponemal antibody 
absorption
Table 2: Clinical features seen in the childhood SLE
Features Number of children Percentage
Fever 14 100
Renal involvement 8 57
Serositis 7 50
Musculoskeletal 6 42
Skin lesions 6 42
Pulmonary 6 42
Neuropsychiatric 5 35
Oral ulcers 4 28
Cardiac 4 28
Lymphadenopathy 4 28
Gastrointestinal 3 21
SLE: Systemic lupus erythematosus
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Laboratory investigations of the studied patients showed 
raised ESR in 12 (85%) cases. Anemia was seen in 10 (71%) 
children, thrombocytopenia in 6 (42%), leukopenia in 5 (35%), 
and hemolytic anemia was seen in 4 (28%) patients. Renal 
involvement in the form of proteinuria in 4 (28%), and hematuria 
in 3 (21%) cases was observed. Results of immunological 
studies are given in Table 3. ANA was positive in all 14 (100%) 
patients while anti-dsDNA was positive in 12 (85%) children 
and anti-Smith antibody in 3 (21%) cases. Low C3 and C4 were 
found in 7 (50%) patients.
DISCUSSION
SLE is a rare disease in children with 15-20% of adult SLEs 
presenting in childhood or in adolescence. The male:female 
ratio is 3:4 before puberty and increases to 1:4, more in females 
in older age groups [1]. However, the median age of SLE onset 
in a study by Malaviya et al. was 24.5 years with a female 
preponderance of 11:1 [3]. In the present study, the mean age 
of presentation was 9.8 years with a male: female ratio of 1:6 
which is also comparable with other studies from India [1,3,5].
The presence of anemia, arthritis, and seizures at the time 
of presentation results in the increased chances of severe 
disease with the attendant poor outcome as outlined in other 
studies [9,10]. In the present study, the majority of the children 
(71%) had presenting symptoms of a single system initially, and 
the initial provisional diagnosis and primary treatment offered 
Figure 2: Classical butterfly rash of systemic lupus 
erythematosus
Figure 3: Painless mouth ulcer involving the hard palate
Figure 1: Focal proliferative lupus nephritis International 
Society of Nephrology/Renal Pathology Society Class 
III-(A)
Figure 5: Edema and lymphocytic infiltrate of superficial 
dermis along with focal vacuolar degeneration of basal cell 
layer. Endothelial destruction, extravasation of RBCs are 
also seen suggesting severe leukocytoclastic vasculitis
Figure 4: (a-c) Skin lesions in systemic lupus erythematosus. 
Cutaneous vasculitis of foot and ear lobule in adolescent girl 
a b c
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was aimed at the predominant symptom and system involved. 
SLE was thought of as a possible diagnosis only when the child 
had an atypical course or an obvious laboratory abnormality 
which in turn delayed the final diagnosis. These initial 
provisional diagnoses varied from viral hemorrhagic fever, 
nutritional anemia, PUO, seizure disorder, and pneumonia to 
acute glomerulonephritis.
In our study, a final diagnosis of SLE was made on the basis 
of multisystemic involvement, atypical course of the initial 
primary disease and laboratory abnormalities. Hematological 
manifestations were very common (78%) with raised ESR seen 
in 85% of cases and anemia in 71%. Some of the children with 
anemia were treated unsuccessfully with hematinics initially. 
Immunological abnormalities (Table 3) were seen in all 
patients with 100% ANA positivity. This is probably because 
the diagnosis of SLE was suspected in most children when they 
were admitted to our hospital with acute flares. One of our male 
patients was even confused with child abuse as he was unwell 
for 2-3 months with abdominal pain and on and off diarrhea 
secondary to colitis (Fig. 6).
Pulmonary involvement in childhood SLE includes pleuritis, 
lupus pneumonia, chronic interstitial lung disease, alveolar 
hemorrhage, and pulmonary fibrosis. It can also cause respiratory 
muscle myopathy and pulmonary hypertension [11-13]. In our 
study, 42% of children had pulmonary involvement with many 
being initially treated for pneumonia without relief and some 
undergoing prolonged admissions for PUO. Subsequently, 
we found 6 cases (including 2 cases of pleural effusion) with 
lupus pneumonia and 4 (28%) with pulmonary hemorrhage 
and pulmonary hemosiderosis. Nervous system manifestations 
including organic brain syndrome, seizures, psychosis, chorea, 
cerebrovascular accident, neuropathy, cranial nerve palsy, 
benign intracranial hypertension, anxiety, and depression 
have been reported in childhood SLE [14]. In our series, 35% 
of children had nervous system involvement in the form of 
seizures, chorea, psychosis, and stroke.
The diagnosis of SLE should be suspected in children, especially 
adolescent girls, who present with vague musculoskeletal 
symptoms such as myalgias, arthralgias, fatigue, and fever. No 
or poor response to treatment of initially diagnosed disease with 
varied and atypical clinical features involving multiple systems 
or an unexplained multisystem disease with or without typical 
skin rash can help in early recognition of the illness. Studies such 
as this present the varied manifestations of the illness in a wide 
spectrum of the regional childhood population and highlight this 
very aspect of the disease in this country.
The major limitation of our study was that it’s a retrospective 
analysis of records of SLE cases after the diagnosis and 
management. Further large scale, multicentric studies involving 
large sample size will throw more light on the overall disease, 
the outcome of each case, factors affecting the treatment and 
their prognosis.
CONCLUSION
SLE in children has varied clinical and laboratory presentations 
depending on the major organs involved. Any child with 
multisystem involvement, prolonged unexplained fever and 
atypical clinical manifestations should be evaluated for SLE. 
A high index of suspicion is needed for the early diagnosis of 
SLE in children.
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